女性健康診断の世界市場レポート 2024年

女性健康診断市場規模は近年力強く成長しています。2023年の329億米ドルから2024年には355億6,000万米ドルへと、CAGR8.1％で拡大します。この期間に見られた拡大は、意識の高まりと教育、40歳以上の女性人口の増加、女性の健康に取り組む政府の取り組み、予防ヘルスケアの動向、ライフスタイルと健康に関する懸念の変化によるものです。

女性健康診断市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR8.5％で492億7,000万米ドルに成長します。予測期間中に拡大が見込まれる背景には、生殖に関する健康問題の増加、女性の高齢化の急増、個別化医療の進歩、遺伝子検査の影響力の拡大、非感染性疾患の重視の高まりなどがあります。この予測期間に予想される主な動向には、更年期管理、予防・早期発見対策の重視、包括性と多様性の重視、パンデミック主導のデジタル化の影響、環境・ライフスタイル要因に関する考察などが含まれます。

女性健康診断市場の予想される成長は、慢性疾患の有病率の増加によって推進されると予想されます。慢性疾患は、一般的に徐々に進行し、継続的な管理とケアを必要とする永続的な疾患です。このような疾病の有病率の高まりは、乳がん、子宮頸がん、生殖障害のような疾病の特定とモニタリングに不可欠な女性健康診断薬に対する需要の高まりを生み出しています。例えば、米国国立医学図書館（National Library of Medicine）のデータによると、2050年までに米国で少なくとも1つの慢性疾患を持つ50歳以上の高齢者の数は1億4,266万人に達すると予測されており、女性の慢性疾患の増加が女性健康診断市場の成長の重要な原動力となっていることが明らかになっています。

個別化医療に対する需要の高まりは、女性健康診断市場の成長を促進します。個別化医療とは、個人の遺伝子やタンパク質に関する知識を利用して、病気を予防、発見、治療することです。このアプローチにより、ヘルスケアプロバイダーは女性特有の遺伝的、分子的、臨床的プロファイルに合わせた治療計画を立てることができ、多くの場合、遺伝子マーカーや特定のバイオマーカーに基づく標的治療が行われます。米国を拠点とする専門家会員組織である個別化医療連合（Personalized Medicine Coalition）の報告によると、2022年に米国食品医薬品局（FDA）は12の個別化医薬品を承認し、新たに承認された治療用分子実体の約34％を占めました。したがって、個別化医療に対する需要の高まりは、女性健康診断市場の成長にとって重要な促進要因となっています。

北米は、2023年の女性健康診断市場において最大の地域でした。アジア太平洋は、予測期間中、世界の女性健康診断市場レポートにおいて最も急成長する地域となる見込みです。女性健康診断市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の女性健康診断市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 付属品と消耗品
• 診断検査
• 診断装置
• 世界の女性健康診断市場、用途別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 骨粗鬆症検査
• 卵巣がん検査（OVC）
• 子宮頸がん検査
• 乳がん検査
• 妊娠と生殖能力の検査
• 出生前遺伝子スクリーニングと保因者検査
• 感染症検査
• 性感染症（STD）検査
• 超音波検査
• 世界の女性健康診断市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院と診療所
• 診断および画像センター
• 在宅ケア
• その他のエンドユーザー

第7章 地域および国の分析

• 世界の女性健康診断市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の女性健康診断市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 女性健康診断市場の競合情勢
• 女性健康診断市場の企業プロファイル
  • Becton Dickinson And Company
  • F. Hoffmann-La Roche AG
  • General Electric Company
  • Koninklijke Philips NV
  • Quest Diagnostics Incorporated

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

“Womens Health Diagnostics Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on womens health diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for womens health diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The womens health diagnostics market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Type: Accessories And Consumables; Diagnostic Tests; Diagnostic Devices
• 2) By Application: Osteoporosis Testing; Ovarian Cancer Testing (OVC); Cervical Cancer Testing; Breast Cancer Testing; Pregnancy And Fertility Testing; Prenatal Genetic Screening And Carrier Testing; Infectious Disease Testing; Sexually Transmitted Diseases (STD) Testing; Ultrasound Tests
• 3) By End User: Hospitals And Clinics; Diagnostic And Imaging Centers; Homecare; Other End Users
• Companies Mentioned: Becton Dickinson And Company; F. Hoffmann-La Roche AG; General Electric Company; Koninklijke Philips N.V.; Quest Diagnostics Incorporated
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Women's health diagnostics encompass medical examinations and procedures employed to assess and diagnose a range of health conditions and diseases specifically impacting women. These diagnostic measures play a crucial role in early identification of health issues, enabling timely and appropriate treatment and management to enhance outcomes and overall quality of life.

The primary categories of women's health diagnostics include accessories and consumables, diagnostic tests, and diagnostic devices. Accessories and consumables encompass a variety of supplementary items and materials utilized in diagnostic procedures tailored to women's health. These items contribute to improving the accuracy, convenience, and effectiveness of diagnostic tests and examinations for women. Applications of these accessories and consumables span diverse areas such as osteoporosis testing, ovarian cancer testing (OVC), cervical cancer testing, breast cancer testing, pregnancy and fertility testing, prenatal genetic screening, carrier testing, infectious disease testing, sexually transmitted disease (STD) testing, and ultrasound testing. These diagnostics find application across various end users, including hospitals and clinics, diagnostic and imaging centers, homecare settings, and other relevant end-user contexts.

The women's health diagnostics market research report is one of a series of new reports from The Business Research Company that provides women's health diagnostics market statistics, including women's health diagnostics industry global market size, regional shares, competitors with a women's health diagnostics market share, detailed women's health diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the women's health diagnostics industry. This women's health diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The womens health diagnostics market size has grown strongly in recent years. It will grow from $32.9 billion in 2023 to $35.56 billion in 2024 at a compound annual growth rate (CAGR) of 8.1%. The expansion observed in the historical period can be ascribed to heightened awareness and education, a growing female population aged over 40, government initiatives addressing women's health, trends in preventive healthcare, and shifts in lifestyles and health-related concerns.

The womens health diagnostics market size is expected to see strong growth in the next few years. It will grow to $49.27 billion in 2028 at a compound annual growth rate (CAGR) of 8.5%. The anticipated expansion in the forecast period can be credited to the increasing occurrence of reproductive health issues, a burgeoning aging female population, advancements in personalized medicine, the widening influence of genetic testing, and a heightened emphasis on non-communicable diseases. Key trends expected in this forecast period encompass menopause management, emphasis on preventive and early detection measures, a focus on inclusivity and diversity, the impact of pandemic-driven digitalization, and considerations related to environmental and lifestyle factors.

The anticipated growth in the women's health diagnostics market is expected to be propelled by the increasing prevalence of chronic diseases. Chronic diseases are enduring conditions that typically progress gradually, necessitating ongoing management and care. The escalating prevalence of these conditions creates a heightened demand for women's health diagnostics, essential for identifying and monitoring diseases such as breast cancer, cervical cancer, and reproductive disorders. For example, data from the National Library of Medicine, a US-based agency, revealed that by 2050, the number of individuals in the US aged 50 and older with at least one chronic condition is projected to reach 142.66 million, underscoring how the rise in chronic diseases among women is a key driver for the growth of the women's health diagnostics market.

The increasing demand for personalized medicine is poised to drive the growth of the women's health diagnostics market. Personalized medicine involves utilizing knowledge about an individual's genes or proteins to prevent, detect, or treat diseases. This approach enables healthcare providers to develop treatment plans tailored to a woman's unique genetic, molecular, and clinical profile, often involving targeted therapies based on genetic markers or specific biomarkers. In 2022, the US Food and Drug Administration (FDA) approved 12 personalized medicines, constituting around 34% of all newly approved therapeutic molecular entities, as reported by the Personalized Medicine Coalition, a US-based professional membership organization. Hence, the increasing demand for personalized medicine is a significant driver for the growth of the women's health diagnostics market.

The prevailing trend gaining momentum in women's health diagnostics is technological advancements in personalized health solutions. Major players within the women's health diagnostics market are directing their efforts towards technological innovations and the development of new products to enhance diagnostic capabilities and maintain their market position. For example, in February 2022, FemTec Health, Inc., a US-based women's health company, introduced a direct-to-consumer (D2C) brand named Awesome Woman, offering personalized health and wellness products for women across various life stages. The brand employs AI, machine learning, and customer data encompassing genomics, genetics, and health history to create customized offerings. These personalized subscription boxes may include vitamins, probiotics, and at-home tests tailored to individual needs. Users can choose specific health focus areas such as vaginal and urinary health, reproductive health, hormone balance, and beauty. Additionally, the service provides telehealth support to enhance the overall customer experience and accessibility to healthcare professionals.

Prominent companies in the women's health diagnostics market are concentrating on product innovations, exemplified by the development of premium ultrasound systems, to reinforce their market standing. A premium ultrasound system is an advanced medical imaging device designed for detailed and high-quality imaging of internal structures in the human body, specifically tailored for obstetrics and gynecology within Samsung's HERA platform. In February 2023, Samsung's digital radiography and ultrasound business unveiled the HERA W10 Elite, a cutting-edge women's health ultrasound system. This system is equipped with a suite of artificial intelligence (AI) tools and clinical applications, signifying a significant advancement in the diagnostic experience for women's health. The HERA W10 Elite features advanced capabilities such as MV-Flow for displaying blood flow intensity, BiometryAssist for convenient fetal growth parameter measurement, and precise analytics to aid clinicians in diagnosis.

In May 2021, Ro, a US-based healthcare company specializing in virtual consultations and telehealth services, acquired Modern Fertility for an undisclosed amount. Through this acquisition, Ro aims to integrate Modern Fertility into its nationwide platform, enhancing operational capabilities and expanding personalized healthcare experiences. This strategic move allows Modern Fertility to accelerate growth, broaden its community, and provide additional tools and services to empower women in their health and future prospects, leveraging Ro's established infrastructure. Modern Fertility, a US-based company, specializes in developing home diagnostic kits for women.

Major companies operating in the womens health diagnostics market report are Becton Dickinson And Company, F. Hoffmann-La Roche AG, General Electric Company, Koninklijke Philips N.V., Quest Diagnostics Incorporated, Siemens Healthineers, Abbott Laboratories, BioMerieux SA, Hologic Inc., PerkinElmer Inc., Cardinal Health Inc., Alere Inc., Carestream Health Inc., Mankind Pharma Limited, Procter & Gamble Co., Trinity Biotech plc, Medgyn Products Inc., URIT Medical Electronic Co. Ltd, Sonic Healthcare Limited, Fujifilm Holdings Corporation, Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Genomic Health Inc., Invitae Corporation, Natera Inc., QIAGEN N.V., Opko Health Inc., Sysmex Corporation, Exact Sciences Corporation, Foundation Medicine Inc., Laboratory Corporation of America Holdings, NeoGenomics Laboratories Inc.

North America was the largest region in the women's health diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global women's health diagnostics market report during the forecast period. The regions covered in the womens health diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the womens health diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The women's health diagnostics market includes revenues earned by entities by providing women's health diagnostics, including pregnancy tests, breast imaging equipment, and hormone level tests. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Womens Health Diagnostics Market Characteristics

3. Womens Health Diagnostics Market Trends And Strategies

4. Womens Health Diagnostics Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Womens Health Diagnostics Market Size and Growth

• 5.1. Global Womens Health Diagnostics Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Womens Health Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Womens Health Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Womens Health Diagnostics Market Segmentation

• 6.1. Global Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Accessories And Consumables
• Diagnostic Tests
• Diagnostic Devices
• 6.2. Global Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Osteoporosis Testing
• Ovarian Cancer Testing (OVC)
• Cervical Cancer Testing
• Breast Cancer Testing
• Pregnancy And Fertility Testing
• Prenatal Genetic Screening And Carrier Testing
• Infectious Disease Testing
• Sexually Transmitted Diseases (STD) Testing
• Ultrasound Tests
• 6.3. Global Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals And Clinics
• Diagnostic And Imaging Centers
• Homecare
• Other End Users

7. Womens Health Diagnostics Market Regional And Country Analysis

• 7.1. Global Womens Health Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Womens Health Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Womens Health Diagnostics Market

• 8.1. Asia-Pacific Womens Health Diagnostics Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Womens Health Diagnostics Market

• 9.1. China Womens Health Diagnostics Market Overview
• 9.2. China Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Womens Health Diagnostics Market

• 10.1. India Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Womens Health Diagnostics Market

• 11.1. Japan Womens Health Diagnostics Market Overview
• 11.2. Japan Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Womens Health Diagnostics Market

• 12.1. Australia Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Womens Health Diagnostics Market

• 13.1. Indonesia Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Womens Health Diagnostics Market

• 14.1. South Korea Womens Health Diagnostics Market Overview
• 14.2. South Korea Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Womens Health Diagnostics Market

• 15.1. Western Europe Womens Health Diagnostics Market Overview
• 15.2. Western Europe Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Womens Health Diagnostics Market

• 16.1. UK Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Womens Health Diagnostics Market

• 17.1. Germany Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Womens Health Diagnostics Market

• 18.1. France Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Womens Health Diagnostics Market

• 19.1. Italy Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Womens Health Diagnostics Market

• 20.1. Spain Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Womens Health Diagnostics Market

• 21.1. Eastern Europe Womens Health Diagnostics Market Overview
• 21.2. Eastern Europe Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Womens Health Diagnostics Market

• 22.1. Russia Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Womens Health Diagnostics Market

• 23.1. North America Womens Health Diagnostics Market Overview
• 23.2. North America Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Womens Health Diagnostics Market

• 24.1. USA Womens Health Diagnostics Market Overview
• 24.2. USA Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Womens Health Diagnostics Market

• 25.1. Canada Womens Health Diagnostics Market Overview
• 25.2. Canada Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Womens Health Diagnostics Market

• 26.1. South America Womens Health Diagnostics Market Overview
• 26.2. South America Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Womens Health Diagnostics Market

• 27.1. Brazil Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Womens Health Diagnostics Market

• 28.1. Middle East Womens Health Diagnostics Market Overview
• 28.2. Middle East Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Womens Health Diagnostics Market

• 29.1. Africa Womens Health Diagnostics Market Overview
• 29.2. Africa Womens Health Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Womens Health Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Womens Health Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Womens Health Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Womens Health Diagnostics Market Competitive Landscape
• 30.2. Womens Health Diagnostics Market Company Profiles
  • 30.2.1. Becton Dickinson And Company
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. F. Hoffmann-La Roche AG
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. General Electric Company
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Koninklijke Philips N.V.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Quest Diagnostics Incorporated
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Womens Health Diagnostics Market Competitive Benchmarking

32. Global Womens Health Diagnostics Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Womens Health Diagnostics Market

34. Womens Health Diagnostics Market Future Outlook and Potential Analysis

• 34.1 Womens Health Diagnostics Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Womens Health Diagnostics Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Womens Health Diagnostics Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer